Franklin Resources Inc Synlogic, Inc. Transaction History

Franklin Resources Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.91 - $14.63 $801 - $12,889	881 Added 1.14%	77,998 $74,000
Q2 2022 Aug 11, 2022	SELL	$0.89 - $2.47 $22,234 - $61,708	-24,983 Reduced 24.47%	77,117 $89,000
Q1 2022 May 13, 2022	BUY	$1.63 - $2.55 $1,070 - $1,675	657 Added 0.65%	102,100 $245,000
Q4 2021 Feb 11, 2022	SELL	$2.27 - $3.0 $583 - $771	-257 Reduced 0.25%	101,443 $245,000
Q3 2021 Nov 12, 2021	BUY	$2.45 - $4.1 $249,165 - $416,969	101,700 New	101,700 $310,000
Q1 2018 May 10, 2018	SELL	$9.38 - $12.12 $1.85 Million - $2.4 Million	-197,722 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$11.55 - $21.79 $2.28 Million - $4.31 Million	197,722	197,722 $3.76 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.